Over the past 12 months, 8 insiders at Stoke Therapeutics, Inc. filed 84 open-market SEC Form 4 transactions on STOK: 0 purchases worth $0 and 84 sales worth $12.2M. Insiders have been net sellers over this period. The most recent filing was on Jul 1, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 1, 26 | Barry TichoCHIEF MEDICAL OFFICER | SELL | 6.7K | $33.27 | $219K |
| Jun 16, 26 | Jonathan AllanGENERAL COUNSEL & CORP SEC | SELL | 1.5K | $29.95 | $44K |
| Mar 20, 26 | Jonathan AllanGENERAL COUNSEL & CORP SEC | SELL | 8.7K | $34.41 | $292K |
| Mar 19, 26 | Barry TichoCHIEF MEDICAL OFFICER | SELL | 1.5K | $29.99 | $44K |
| Mar 18, 26 | Jonathan AllanGENERAL COUNSEL & CORP SEC | SELL | 4.2K | $32.85 | $132K |
| Mar 18, 26 | Jason HoittChief Patient Officer | SELL | 1.8K | $32.85 | $55K |
| Mar 18, 26 | Thomas LeggettChief Financial Officer | SELL | 2.2K | $32.85 | $68K |
| Mar 18, 26 | Barry TichoCHIEF MEDICAL OFFICER | SELL | 6.1K | $32.85 | $191K |
| Mar 17, 26 | Jonathan AllanGENERAL COUNSEL & CORP SEC | SELL | 2.5K | $33.38 | $81K |
| Mar 17, 26 | Jason HoittChief Patient Officer | SELL | 1.0K | $33.38 | $34K |
| Mar 17, 26 | Thomas LeggettChief Financial Officer | SELL | 1.3K | $33.38 | $42K |
| Mar 17, 26 | Barry TichoCHIEF MEDICAL OFFICER | SELL | 3.6K | $33.38 | $117K |
| Mar 13, 26 | Arthur A LevinDirector | SELL | 605 | $36.80 | $22K |
| Mar 10, 26 | Adrian R. KrainerDirector | SELL | 33.2K | $39.74 | $1.3M |
| Mar 10, 26 | Arthur TzianabosInterim Executive Chair | SELL | 4.4K | $40.00 | $174K |
| Mar 2, 26 | Adrian R. KrainerDirector | SELL | 7.2K | $39.66 | $287K |
| Dec 8, 25 | Jonathan AllanGENERAL COUNSEL & CORP SEC | SELL | 2.7K | $32.61 | $87K |
| Dec 8, 25 | Kaye Edward M. MdDirector | SELL | 8.3K | $33.10 | $269K |
| Dec 5, 25 | Jonathan AllanGENERAL COUNSEL & CORP SEC | SELL | 5.4K | $31.76 | $169K |
| Dec 5, 25 | Kaye Edward M. MdDirector | SELL | 6.4K | $31.85 | $199K |
| Dec 5, 25 | Barry TichoCHIEF MEDICAL OFFICER | SELL | 2.0K | $31.35 | $62K |
| Dec 4, 25 | Jonathan AllanGENERAL COUNSEL & CORP SEC | SELL | 824 | $31.32 | $25K |
| Dec 4, 25 | Kaye Edward M. MdDirector | SELL | 5.2K | $31.32 | $161K |
| Dec 4, 25 | Barry TichoCHIEF MEDICAL OFFICER | SELL | 1.4K | $31.32 | $42K |
| Dec 3, 25 | Jonathan AllanGENERAL COUNSEL & CORP SEC | SELL | 1.4K | $30.85 | $43K |
| Dec 3, 25 | Kaye Edward M. MdDirector | SELL | 651 | $30.85 | $20K |
| Dec 3, 25 | Barry TichoCHIEF MEDICAL OFFICER | SELL | 1.2K | $30.85 | $38K |
| Dec 2, 25 | Jonathan AllanGENERAL COUNSEL & CORP SEC | SELL | 1.4K | $30.14 | $42K |
| Dec 2, 25 | Kaye Edward M. MdDirector | SELL | 661 | $30.14 | $20K |
| Dec 2, 25 | Barry TichoCHIEF MEDICAL OFFICER | SELL | 1.2K | $30.14 | $37K |
| Nov 24, 25 | Adrian R. KrainerDirector | SELL | 40.5K | $29.72 | $1.2M |
| Nov 14, 25 | Adrian R. KrainerDirector | SELL | 20.7K | $27.34 | $565K |
| Nov 3, 25 | Barry TichoCHIEF MEDICAL OFFICER | SELL | 3.8K | $29.35 | $95K |
| Oct 8, 25 | Kaye Edward M. MdDirector | SELL | 25.0K | $30.00 | $750K |
| Oct 3, 25 | Jonathan AllanGENERAL COUNSEL & CORP SEC | SELL | 10.0K | $25.07 | $251K |
| Oct 3, 25 | Kaye Edward M. MdDirector | SELL | 42.5K | $25.09 | $1.1M |
| Oct 1, 25 | Barry TichoCHIEF MEDICAL OFFICER | SELL | 5.3K | $23.64 | $126K |
| Sep 3, 25 | Jonathan AllanGENERAL COUNSEL & CORP SEC | SELL | 6.3K | $20.07 | $127K |
| Sep 3, 25 | Kaye Edward M. MdDirector | SELL | 46.0K | $20.13 | $926K |
| Sep 2, 25 | Barry TichoCHIEF MEDICAL OFFICER | SELL | 5.5K | $19.87 | $109K |
| Sep 2, 25 | Jonathan AllanGENERAL COUNSEL & CORP SEC | SELL | 14.9K | $20.14 | $301K |
| Sep 2, 25 | Kaye Edward M. MdDirector | SELL | 14.9K | $20.14 | $299K |
| Aug 29, 25 | Jonathan AllanGENERAL COUNSEL & CORP SEC | SELL | 850 | $20.00 | $17K |
| Aug 29, 25 | Kaye Edward M. MdDirector | SELL | 1.0K | $20.00 | $21K |
| Aug 18, 25 | Jonathan AllanGENERAL COUNSEL & CORP SEC | SELL | 1.7K | $18.24 | $31K |
| Aug 18, 25 | Kaye Edward M. MdDirector | SELL | 12.1K | $18.24 | $221K |
| Aug 18, 25 | Barry TichoCHIEF MEDICAL OFFICER | SELL | 2.8K | $18.24 | $51K |
| Aug 13, 25 | Jonathan AllanGENERAL COUNSEL & CORP SEC | SELL | 13.7K | $15.00 | $206K |
| Aug 1, 25 | Barry TichoCHIEF MEDICAL OFFICER | SELL | 4.5K | $12.82 | $58K |
| Jul 1, 25 | Barry TichoCHIEF MEDICAL OFFICER | SELL | 4.5K | $11.63 | $52K |
Over the past 12 months, insiders at Stoke Therapeutics, Inc. filed 0 open-market purchases worth $0 and 84 sales worth $12.2M on STOK, which makes them net sellers over the period. The most recent Form 4 was filed on Jul 1, 26.
8 different insiders at Stoke Therapeutics, Inc. filed open-market SEC Form 4 transactions on STOK over the last 12 months.
InsiderTape plots every STOK insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Stoke Therapeutics, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →